PGEN (Precigen Inc) Sof foyda

PGEN (Precigen) - kompaniyaning tovar belgisi

Precigen, Inc. (PGEN) kompaniyasining bozor kapitalizatsiyasi tendentsiyasi tadqiqot va ishlanmalar (R&D) xarajatlari mavjud rezervlar hisobidan qoplanadigan kompaniya dinamikasini aks ettiradi va joriy ko'rsatkich -0.34 ni tashkil etadi. Biznes UltraVector platformasiga tayanadi, bunda PRGN-2012 sinovlari va FDA tasdiqlari asosiy o'sish drayverlariga aylandi. Sintetik biologiya onkologik terapiya uchun genlarni dasturlash imkonini berib, zamonaviy tibbiyotning texnologik poydevorini yaratmoqda.

PGEN (Precigen, Inc.) Sof foyda tarixi 04.07.2022dan 30.10.2026gacha

Precigen (PGEN) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Precigen Corp|PGEN - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Precigen Corp|PGEN - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Precigen|PGEN - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi precigen.com|PGEN - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Precigen, Inc.|PGEN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Precigen Inc|PGEN - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Precigen Corp|PGEN - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Precigen|Shoshilinch likvidlik precigen.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
PGEN - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Precigen, Inc.
Intrexon asosiy tovari

Sof daromadni aniq monitoring qilish tebranishlar davrida kapital risklarini minimallashtirish uchun juda muhimdir. Ushbu metrika hisobotdagi kechikishlarni hisobga olmagan holda, biznesning yakuniy operatsion samaradorligini o'lchaydi. GURU.Markets platformasida Precigen, Inc. (PGEN) kompaniyasining joriy foyda darajalarini tahlil qilish orqali investor aktivning haqiqiy moliyaviy barqarorligini aniqlashi mumkin. Ushbu ko'rsatkichning tendentsiyasi Precigen, Inc. (PGEN) kompaniyasining diversifikatsiyalashgan gen terapiyasi loyihalari portfelining hayotiyligini tasdiqlaydi va ko'p profilli klinik ishlanmalar umumiy daromadlilikka qanday ta'sir qilishini baholash imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PHAR - Kompaniyaning sof foydasi|Soliqdan keyingi foyda NKTR|Upstream Bio Inc (UPB) - Kompaniyaning sof foydasi|zenasbio.com - Yakuniy foyda|IMNM (Immunome) - Sof foyda|Kompaniyaning sof daromadi Gossamer Bio Inc GOSS|Sof foyda KALV|Sof daromad Septerna Pharma SEPN|Sof foyda PVLA (Pieris Pharmaceuticals)|Sof moliyaviy natija savarapharma.com (SVRA)|Rigel Pharmaceuticals, Inc. - Sof foyda|Yillik sof foyda AnaptysBio Inc (ANAB)|ATXS: Sof foyda|Kompaniyaning sof daromadi enGene Corp (ENGN)|Kompaniyaning sof foydasi RAPT Therapeutics, Inc.|Kompaniya foydasi JBIO (Aerovate)|Sof daromad ACRS (Aclaris Therapeutics, Inc.)|KYTX (Kyverna Therapeutics Inc.) - Yakuniy foyda|Sof foyda TLSA (Tiziana Life Sciences PLC)|Sof moliyaviy natija Cabaletta Bio Inc (CABA)|VTYX - Kompaniyaning sof foydasi|THTX (theratech.com) - Kompaniya foydasi|AVTX: Sof foyda|Sof daromad Eledon Pharmaceuticals Inc.|Sof daromad AGEN|Climb Bio, Inc (CLYM) - Sof moliyaviy natija|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|ATYR: Soliqdan keyingi foyda|Sof foyda ADAG (Adagene Inc.)|Yillik sof foyda ImageneBio|Shattuck Therapeutics - Sof foyda|Kompaniyaning sof daromadi Equillium, Inc.|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|Kompaniya foydasi IMUX|Kompaniyaning sof foydasi Atara Biotherapeutics, Inc.|InflaRx GmbH - Soliqdan keyingi foyda|Sof foyda XFOR|ACET (adicetbio.com) - Yakuniy foyda|Sof foyda CELU (Celularity)|Sof foyda inmunebio.com INMB|BRNS - Kompaniyaning sof foydasi|Yakuniy foyda KZR (Kezar Life Sciences Inc.)|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|Sof daromad Akari Therapeutics, Plc|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Sof foyda Q32 Bio Corp|Sof daromad GOVX (GeoVax)|EDSA (Edesa Biotech Inc) - Yakuniy foyda|Sof foyda IBIO (iBio Corp)|Sof moliyaviy natija Carisma Therapeutics Inc (CARM)|XTLB - Kompaniyaning sof foydasi|Bolt Biotherapeutics (BOLT) - Sof daromad|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Sof daromad Aptevo Therapeutics Inc.|Sof daromad AIM|Sof foyda Aditxt Corp|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|xortx.com - Kompaniya foydasi|Sof foyda HIND (Vyome Holdings)|Revelation Biosciences Inc (REVB) - Kompaniyaning sof daromadi|INDP - Kompaniyaning sof foydasi|Soliqdan keyingi foyda SCNI|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Affimed N.V. - Yakuniy foyda|ALLK (Allakos Inc) - Sof foyda|Kompaniyaning sof daromadi HOOKIPA HOOK|Sof foyda IGMS|Sof daromad iTeos Pharma ITOS|Sof foyda OCEA (Ocean Biomedical, Inc.)|Sof moliyaviy natija tcbiopharm.com (TCBP)|Third Harmonic Bio, Inc. - Sof foyda